CHANGES IN THE AMOUNT OF LIPIDS UNDER THE INFLUENCE OF NATURAL BIOLOGICALLY ACTIVE FOOD SUPPLEMENTES IN EXPERIMENTAL DIABETES

Authors

  • Asqarov Ibrohimjon Rakhmonovich professor of Andijan State University, honored inventor of Uzbekistan, chairman of the Academy of Medicine of Uzbekistan Author
  • Mo’minova Guyoxon Alidjonovna associate professor of Andijan State Medical Institute, PhD Author

Keywords:

Diabetes, natural biologically active food supplement, hyperlipidemia, triacylglyceride, glucose.

Abstract

Shifo and As-GAM natural biologically active food supplement (NBAFS) of the effects of alloxan-induced diabetes in rats by changes in blood lipid spectrum.

Downloads

Download data is not yet available.

References

International Diabetes Federation. IDF Diabetes Atlas. 9th edn. Brussels, Belgium:

International Diabetes Federation; 2019. http://www.diabetesatlas.org.

NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since

: a pooled analysis of 751 population-based studies with 4.4 million

participants. Lancet 2016;387(10027):1513–30. https://doi.org/10.1016/s0140-

(16)00618-8.

Sugden M, Holness M. Pathophysiology of diabetic dyslipidemia: Implications for atherogenesis and treatment. Clin. Lipidol. 2011;6:401–411. doi: 10.2217/clp.11.32. [CrossRef] [Google Scholar]

Jones JL, Park Y, Lee J, Lerman RH, Fernandez ML. A Mediterranean-style, low-glycemic-load diet reduces the expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in mononuclear cells and plasma insulin in women with metabolic syndrome. Nutr. Res. 2011;31:659–664. doi: 10.1016/j.nutres.2011.08.011. [PubMed] [CrossRef] [Google Scholar]

D.G. Menzies, I.W. Campbell, A. McBain, I.R.F. Brown.Metformin efficacy and tolerance in obese non-insulin dependent diabetics: a comparison of two dosage schedules.(2008), pp. 273-278 Google Scholar

A. Chaudhury, C. Duvoor, V.S. Reddy Dendi, S. Kraleti, A. Chada, R. Ravilla, A. Marco, N.S. Shekhawat, M.T. Montales, K. Kuriakose, A. Sasapu, A. Beebe, N. Patil, C.K. Musham, G.P. Lohani, W. Mirza. Clinical review of anti-diabetic drugs: Implications for type 2 diabetes mellitus management.Front. Endocrinol., 8 (2017), p. 6 View in ScopusGoogle Scholar

Downloads

Published

2024-07-01